XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel
· Delayed Price · Currency is ILS · Price in ILA 4.600
+0.100 (2.22%)
May 13, 2025, 5:24 PM IDT
XTL Biopharmaceuticals Revenue
In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K USD. XTL Biopharmaceuticals had revenue of $405.00K in the quarter ending December 31, 2024.
Revenue
$451.00K
Revenue Growth
n/a
P/S Ratio
24.68
Revenue / Employee
$90.20K
Employees
5
Market Cap
40.54M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 920.37M |
| SofWave Medical | 235.09M |
| BrainsWay | 149.39M |